> These are changes he hasn’t noticed in patients who have lost significant weight in other ways—like through diet or gastric bypass surgery—which makes him think it’s unique to GLP-1 usage.
TFA contains mixed messaging. The part you quoted is discussing face skin, then later, also talking about face skin:
> (“We see a similar pattern in other causes of rapid weight loss, including gastric bypass surgery, he says.) In some cases, the loss of subcutaneous fat is significant enough that it impacts a patients’ ability to get injectables ..
So which is it?
My takeaway was that losing weight fast == problematic.
The article dials up the FUD factor to the max, which makes me question the quality of reporting and any intent to accurately inform vs. just get clicks.
>and any intent to accurately inform vs. just get clicks.
This is missing one option. The source - plastic surgeons - may be people that profit from liposuction treatment. To keep patients they might not want people to use ozempic, or at least get people to notice changes in the face faster and get a facelift.
I had an internship with a researcher who swore skin had different properties between races (not including color). Black populations had a different feel to adipose tissue. I think I could tell but he had examined thousands, he didn’t want to be the guy publishing a paper on that.
